• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并噻唑基和苯并恶唑基腙作为锌金属载体蛋白,可使突变型 p53 重新激活。

Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.

机构信息

Rutgers Molecular Design and Synthesis, Office of Research and Economic Development, Piscataway, New Jersey 08854, United States.

Program of Surgical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey 08901, United States.

出版信息

J Med Chem. 2021 Feb 25;64(4):2024-2045. doi: 10.1021/acs.jmedchem.0c01360. Epub 2021 Feb 4.

DOI:10.1021/acs.jmedchem.0c01360
PMID:33538587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9278656/
Abstract

We identified a set of thiosemicarbazone (TSC) metal ion chelators that reactivate specific zinc-deficient p53 mutants using a mechanism called zinc metallochaperones (ZMCs) that restore zinc binding by shuttling zinc into cells. We defined biophysical and cellular assays necessary for structure-activity relationship studies using this mechanism. We investigated an alternative class of zinc scaffolds that differ from TSCs by substitution of the thiocarbamoyl moiety with benzothiazolyl, benzoxazolyl, and benzimidazolyl hydrazones. Members of this series bound zinc with similar affinity and functioned to reactivate mutant p53 comparable to the TSCs. Acute toxicity and efficacy assays in rodents demonstrated to be significantly less toxic than the TSCs while demonstrating equivalent growth inhibition. We identified as a ZMC with diminished copper binding that functions as a chemotherapy and radiation sensitizer. We conclude that the benzothiazolyl, benzoxazolyl, and benzimidazolyl hydrazones can function as ZMCs to reactivate mutant p53 and .

摘要

我们鉴定了一组硫代卡巴腙(TSC)金属离子螯合剂,它们通过一种称为锌金属伴侣(ZMC)的机制来重新激活特定的锌缺乏型 p53 突变体,该机制通过将锌输送到细胞中来恢复锌结合。我们定义了使用这种机制进行结构-活性关系研究所需的生物物理和细胞测定。我们研究了一类与 TSCs 不同的锌支架,它们通过用苯并噻唑基、苯并恶唑基和苯并咪唑基腙取代硫代碳酰基部分。该系列的成员与锌的结合亲和力相似,并且能够像 TSCs 一样重新激活突变型 p53。在啮齿动物中的急性毒性和功效测定表明,其毒性明显低于 TSCs,同时表现出等效的生长抑制作用。我们确定 是一种与铜结合减少的 ZMC,可作为化疗和放疗增敏剂。我们得出结论,苯并噻唑基、苯并恶唑基和苯并咪唑基腙可以作为 ZMC 来重新激活突变型 p53 和 。

相似文献

1
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.苯并噻唑基和苯并恶唑基腙作为锌金属载体蛋白,可使突变型 p53 重新激活。
J Med Chem. 2021 Feb 25;64(4):2024-2045. doi: 10.1021/acs.jmedchem.0c01360. Epub 2021 Feb 4.
2
Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.作为锌金属伴侣发挥作用以重新激活突变型p53的硫代氨基脲类化合物。
Mol Pharmacol. 2017 Jun;91(6):567-575. doi: 10.1124/mol.116.107409. Epub 2017 Mar 20.
3
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.锌金属伴侣蛋白与突变 p53 再激活和减少铜结合的组合疗法。
Mol Cancer Ther. 2019 Aug;18(8):1355-1365. doi: 10.1158/1535-7163.MCT-18-1080. Epub 2019 Jun 13.
4
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.锌金属伴侣蛋白利用开/关开关机制重新激活突变型 p53:癌症治疗的新范例。
Clin Cancer Res. 2018 Sep 15;24(18):4505-4517. doi: 10.1158/1078-0432.CCR-18-0822. Epub 2018 Jun 18.
5
Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.锌金属伴侣蛋白作为突变型p53激活剂:癌症治疗的新范式
Cancers (Basel). 2018 May 29;10(6):166. doi: 10.3390/cancers10060166.
6
Allele-specific p53 mutant reactivation.等位基因特异性 p53 突变体的重新激活。
Cancer Cell. 2012 May 15;21(5):614-625. doi: 10.1016/j.ccr.2012.03.042.
7
Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.源自α-(N)-酰基杂芳烃的2-苯并恶唑基腙的合成、构效关系及抗肿瘤研究
J Med Chem. 2006 Oct 19;49(21):6343-50. doi: 10.1021/jm060232u.
8
Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.利用一种基于新型锌金属伴侣的机制,小分子恢复突变型p53的野生型结构和功能。
Oncotarget. 2014 Oct 15;5(19):8879-92. doi: 10.18632/oncotarget.2432.
9
Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.利用小分子作为锌金属伴侣激活突变型p53:唤醒癌症中的沉睡巨头。
Drug Discov Today. 2015 Nov;20(11):1391-7. doi: 10.1016/j.drudis.2015.07.006. Epub 2015 Jul 20.
10
Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.改变多功能金属伴侣蛋白中与突变 p53 再激活相关的相对金属结合亲和力。
J Inorg Biochem. 2024 Feb;251:112433. doi: 10.1016/j.jinorgbio.2023.112433. Epub 2023 Nov 22.

引用本文的文献

1
Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application.探索利用细胞内螯合作用和非铁金属调控铁死亡用于抗癌应用。
Inorganics (Basel). 2024 Jan;12(1). doi: 10.3390/inorganics12010026. Epub 2024 Jan 8.
2
Alzheimer's Disease and Cancer: Common Targets.阿尔茨海默病与癌症:共同靶点
Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.
3
Biological Effects of HDAC Inhibitors Vary with Zinc Binding Group: Differential Effects on Zinc Bioavailability, ROS Production, and R175H p53 Mutant Protein Reactivation.

本文引用的文献

1
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.锌塑造了 p53 的折叠景观,并为激活结构多样的癌症突变体建立了一条途径。
Elife. 2020 Dec 2;9:e61487. doi: 10.7554/eLife.61487.
2
Warning on False or True Morels and Button Mushrooms with Potential Toxicity Linked to Hydrazinic Toxins: An Update.警惕具有潜在毒性的假或真羊肚菌和纽扣菇:与肼类毒素有关的更新。
Toxins (Basel). 2020 Jul 29;12(8):482. doi: 10.3390/toxins12080482.
3
Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules.
组蛋白去乙酰化酶抑制剂的生物学效应随锌结合基团而变化:对锌生物利用度、ROS 产生和 R175H p53 突变蛋白的再激活的差异影响。
Biomolecules. 2023 Oct 28;13(11):1588. doi: 10.3390/biom13111588.
4
2-Aminobenzothiazoles in anticancer drug design and discovery.2-氨基苯并噻唑在抗癌药物设计与发现中的应用。
Bioorg Chem. 2023 Jun;135:106477. doi: 10.1016/j.bioorg.2023.106477. Epub 2023 Mar 20.
5
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer.p53 靶向治疗在卵巢癌中的挑战与展望。
Biomolecules. 2023 Jan 12;13(1):159. doi: 10.3390/biom13010159.
6
p53 and Zinc: A Malleable Relationship.p53与锌:一种可塑的关系。
Front Mol Biosci. 2022 Apr 13;9:895887. doi: 10.3389/fmolb.2022.895887. eCollection 2022.
7
A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.生物无机化学在癌症中突变型 p53 复活中的作用。
J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30.
8
Selective Metal Chelation by a Thiosemicarbazone Derivative Interferes with Mitochondrial Respiration and Ribosome Biogenesis in Candida albicans.硫代半卡巴腙衍生物的选择性金属螯合作用干扰白念珠菌的线粒体呼吸和核糖体生物发生。
Microbiol Spectr. 2022 Jun 29;10(3):e0195121. doi: 10.1128/spectrum.01951-21. Epub 2022 Apr 18.
9
Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance.调节细胞内铜水平作为抗癌铜配合物的作用机制:临床相关性
Biomedicines. 2021 Jul 21;9(8):852. doi: 10.3390/biomedicines9080852.
10
Structural and Drug Targeting Insights on Mutant p53.突变型p53的结构与药物靶向见解
Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344.
吗啡啉作为一种特权结构:吗啡啉含生物活性分子的药物化学和药理学活性综述。
Med Res Rev. 2020 Mar;40(2):709-752. doi: 10.1002/med.21634. Epub 2019 Sep 12.
4
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.锌金属伴侣蛋白与突变 p53 再激活和减少铜结合的组合疗法。
Mol Cancer Ther. 2019 Aug;18(8):1355-1365. doi: 10.1158/1535-7163.MCT-18-1080. Epub 2019 Jun 13.
5
Therapeutic targeting of and mutant breast cancer through mutant p53 reactivation.通过恢复突变型p53对携带 和 突变的乳腺癌进行治疗靶向。 (你提供的原文中“ 和 ”部分内容缺失,请补充完整以便能准确翻译。)
NPJ Breast Cancer. 2019 Apr 15;5:14. doi: 10.1038/s41523-019-0110-1. eCollection 2019.
6
Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer.锌金属伴侣蛋白翻转突变型p53的“开关”:短暂的锌脉冲如何重新激活突变型p53以杀死癌细胞。
Oncotarget. 2019 Jan 29;10(9):918-919. doi: 10.18632/oncotarget.26561.
7
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.锌金属伴侣蛋白利用开/关开关机制重新激活突变型 p53:癌症治疗的新范例。
Clin Cancer Res. 2018 Sep 15;24(18):4505-4517. doi: 10.1158/1078-0432.CCR-18-0822. Epub 2018 Jun 18.
8
Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.铜结合小分子诱导脑胶质瘤患者来源细胞的氧化应激和细胞周期停滞。
Cell Chem Biol. 2018 May 17;25(5):585-594.e7. doi: 10.1016/j.chembiol.2018.02.010. Epub 2018 Mar 22.
9
Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.不同α-N-杂环硫代半卡巴腙的代谢途径比较。
Anal Bioanal Chem. 2018 Mar;410(9):2343-2361. doi: 10.1007/s00216-018-0889-x. Epub 2018 Feb 23.
10
Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors.疏水环境中溶剂暴露的蛋白口袋付出的代价:一系列枯草溶菌素抑制剂中,远端增溶基团对亲和力和结合热力学的影响。
J Med Chem. 2017 Jul 13;60(13):5791-5799. doi: 10.1021/acs.jmedchem.7b00490. Epub 2017 Jun 22.